National Priority Voucher Program
The FDA has announced the initial list of program participants, which includes nine medications.
The Priority Voucher program is a new initiative aimed at promoting novel treatments that benefit the health interests of Americans, including medications that meet a large, unmet need or reduce downstream health care utilization.
Medications that utilize MFN pricing can also be considered for the program.
As announced in June, the program is part of the FDA's efforts to support innovative treatments.
The Priority Voucher program promotes novel treatments that benefit Americans' health interests.
Author's summary: FDA announces 9 medications in Priority Voucher program.